Search Results
May 26, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) anuncia que sus tenencias de ETH alcanzan los 5,39 millones de tokens
numerosas condiciones, muchas de las cuales escapan al control de Bitmine, incluidas las establecidas en la sección de Factores de Riesgo del Formulario 10-K de Bitmine presentado ante la SEC el 21 de noviembre de 2025, así como en todos los demás documentos presentados ante la SEC, según se modifiquen o actualicen
More news about: Bitmine Immersion Technologies, Inc.
May 26, 2026, 08:18 ET CGTN: Společná budoucnost: Čína a Srbsko posouvají komplexní strategické partnerství na novou úroveň
byly vyrobeny z oceli vyprodukované právě v tomto závodě a symbolizovaly tak silnější vazby mezi oběma zeměmi.V pondělí se oba prezidenti setkali k jednání v Pekingu. Si vyzval obě země, aby společně vytyčily jasnou cestu ke společné budoucnosti a společné prosperitě a pozvedly komplexní strategické
More news about: CGTN
May 26, 2026, 08:18 ET Hoth Therapeutics Awarded U.S. Patent for Cancer-Fighting HT-KIT Oncology Platform
various important factors, including, without limitation, market conditions and the factors described in the section titled "Risk Factors" in Hoth's most recent Annual Report on Form 10-K and Hoth's other filings made with the U. S. Securities and Exchange Commission. All such statements speak only as of the date made. Consequently, forward-looking
More news about: Hoth Therapeutics, Inc.
May 26, 2026, 08:15 ET Decoy Therapeutics Names Brad Pentelute, MIT Professor of Chemistry, as Chair of Scientific Advisory Board
to carefully review and consider the various disclosures made by the Company in its reports filed with the SEC, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as revised or supplemented by its Quarterly Reports on Form 10-Q and other documents filed with the SEC.
More news about: Decoy Therapeutics, Inc
May 26, 2026, 08:10 ET Menarini Group、American Society of Clinical Oncology (ASCO)の2026年年次総会で新データを発表
ER+/HER2- PI3K/AKT/PTEN- 経路を変化させた転移性乳癌（mBC）患者におけるエラセストラント とカピバセルチブ の併用療法 の安全性と予備的有効性を探る新たなデータが、第 1/2 相ELEVATE 試験より発表されます。現在進行中のエラセストラント併用療法の詳細について、ADELA（エベロリムスとの極めて
More news about: Menarini Industrie Farmaceutiche Riunite
May 26, 2026, 08:05 ET Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference
from those contained in the forward-looking statements, see the section entitled "Risk Factors" in the Company's most recent Annual Report on Form 10-K and subsequent reports filed with the Securities and Exchange Commission.Investor Contact:Steven M. HarasymTel: +1
More news about: Precigen, Inc.
May 26, 2026, 08:00 ET Northwest Bank Names Chad Ballard as Chief Information Officer
actual results to differ materially from those contemplated by such forward-looking statements are described in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 under the section entitled "Item 1A - Risk Factors," and from time to time in other filings made by the Company with
More news about: Northwest Bank
May 26, 2026, 08:00 ET Trinity Capital Inc. Acquires Equipment Leasing Services, Adding a New Income Generating Business to Its Platform
"Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed annual report on Form 10-K and subsequent SEC filings.About Trinity Capital Inc. Trinity Capital Inc. (Nasdaq: TRIN) is an international alternative asset manager
More news about: Trinity Capital Inc.
May 26, 2026, 08:00 ET CLEAR Partners with Samsung, Bringing CLEAR ID to Samsung Wallet
in the Company's filings within the Securities and Exchange Commission, including the sections titled "Risk Factors" in our Annual Report on Form 10- K. The Company disclaims any obligation to update any forward-looking statements contained herein.CLEAR
More news about: CLEAR
May 26, 2026, 08:00 ET Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting
and Exchange Commission and which you should review, including those statements under "Item 1A – Risk Factors" in Genprex's Annual Report on Form 10-K for the year ended December 31, 2025.Because forward-looking statements are subject to risks and uncertainties, actual results may differ materially
More news about: Genprex, Inc.
May 26, 2026, 08:00 ET Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting
www.sec.gov, including in Citius Oncology's Annual Report on Form 10-K for the year ended September 30, 2025, filed with the SEC on December 23, 2025. These forward-looking statements speak only as of the date hereof, and
More news about: Citius Oncology, Inc.
May 26, 2026, 07:42 ET CGTN: Čína a Pákistán potvrzují vzájemné vztahy a zavazují se k prosazování multipolárního světa
společnou budoucností v nové éře a dosáhnout dalších výsledků v rámci své všestranné spolupráce, aby lépe prospívaly obyvatelům obou zemí, přispívaly k regionálnímu míru a stabilitě a byly dobrým příkladem budování komunity se společnou budoucností se sousedními zeměmi.Nerozlučné přátelstvíČtyřdenní
More news about: CGTN
May 26, 2026, 07:34 ET West Bengal Gramin Bank & Canara HSBC Life Insurance Partner to Deepen Rural Insurance coverage
WBGB's focus on empowering rural communities through inclusive financial services.The partnership was formalized in the presence of Shri Alok K Goel, Chairman, West Bengal Gramin Bank; Shri Rajesh Kumar Mishra, General Manager, WBGB; Soly Thomas, Deputy CEO & Chief Distribution Officer – Bancassurance,
More news about: Canara HSBC Life Insurance
May 26, 2026, 07:30 ET Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer
preclinical study in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research ("AACR"), demonstrating that dual PI3K/mTOR inhibition with paxalisib altered tumor cell state and immune signaling in preclinical TNBC models. TNBC accounts for approximately 15 to 20 percent
More news about: Kazia Therapeutics Limited
May 26, 2026, 07:30 ET Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo
time to time in filings with the Securities and Exchange Commission (the "SEC"), including, but not limited to, Soligenix's reports on Forms 10-Q and 10-K. Unless required by law, Soligenix assumes no obligation to update or revise any forward-looking statements as a result of new information or future
More news about: SOLIGENIX, INC.
May 26, 2026, 07:27 ET Merach S29R2: samonabíjecí rotoped, který uživatele osvobozuje od měsíčního předplatného fitness služeb
inteligentní automatický odpor a volitelné připojení k aplikacím, včetně podpory populárních platforem třetích stran, jako jsou Zwift a Kinomap, aniž jsou základní funkce vázány na povinné předplatné. Je navržen pro flexibilní domácí použití a zajišťuje přístup k tréninkům bez nutnosti předplatného.
More news about: Merach
May 26, 2026, 07:20 ET Terra Quantum and Axiom Intelligence Acquisition Corp 1 Announce Definitive Business Combination Agreement at a $3.5 Billion Equity Valuation
detailed information regarding the names, affiliations, and interests of Axiom's directors and executive officers in Axiom's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on March 25, 2026, and in subsequent filings with the SEC, including the proxy
More news about: Terra Quantum
May 26, 2026, 07:20 ET Terra Quantum and Axiom Intelligence Acquisition Corp 1 Announce Definitive Business Combination Agreement at a $3.5 Billion Equity Valuation
detailed information regarding the names, affiliations, and interests of Axiom's directors and executive officers in Axiom's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on March 25, 2026, and in subsequent filings with the SEC, including the proxy
More news about: Terra Quantum
May 26, 2026, 07:00 ET Freightos Reports First Quarter 2026 Results
March 2026 of $23.5 million.Recent Business HighlightsTransactions Growth: Freightos platform facilitated 425k transactions in the first quarter of 2026, up 15% year over year. Excluding routes involving Middle East origin, destination or airspace, transactions
More news about: Freightos
May 26, 2026, 07:00 ET Modine Announces Landmark $4 Billion Long-Term Capacity Agreement through 2029 with Strategic Data Center Customer for Airedale by Modine™ Cooling Solutions
uncertainties, including, but not limited to those described under "Risk Factors" in Item 1A of Part I of the Company's most recent Annual Report on Form 10-K. Other risks and uncertainties include, but are not limited to, the following: the impact of potential adverse developments or disruptions in the global
More news about: Modine
May 26, 2026, 07:00 ET CPRO, a Leader in the Physical AI Security Industry, to be Publicly Listed on a U.S. National Securities Exchange Through Business Combination with Lakeshore Acquisition III Corp.
of Lakeshore's directors and executive officers and a description of their interests in Lakeshore is contained in Lakeshore's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on February 4, 2026 and is available free of charge at the SEC's web site at
More news about: LAKESHORE ACQUISITION III CORP.
May 26, 2026, 06:55 ET Wheels Up Lead Strategic Investor Delta Air Lines Agrees to Extend Lock-Up
We have identified certain known material risk factors applicable to the Company under Part I, Item 1A "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the U.S. Securities and Exchange Commission ("SEC") on March 10, 2026, under Part II, Item 1A "Risk Factors"
More news about: Wheels Up
May 26, 2026, 06:45 ET Lilly announces three acquisitions to build infectious disease portfolio
further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking
More news about: Eli Lilly and Company
May 26, 2026, 06:30 ET Hycroft to Join Russell 3000® Index
effect on our business, cash flows, financial condition and results of operations. Please see the "Risk Factors" outlined in our Annual Report on Form 10-K for the year ended December 31, 2025, and in other reports filed with the SEC, for more information about these and other risks.Given these risks
More news about: Hycroft Mining Holding Corporation
May 26, 2026, 06:30 ET ITURAN PRESENTS FIRST QUARTER 2026 RESULTS
https://us06web.zoom.us/webinar/register/WN_Jx5K81s0TCqmGqEj3AgRdAFor those unable to listen to the live call, a replay of the call will be available from the day after the call
More news about: Ituran Location and Control Ltd.